Veracyte Inc (VCYT) Chairman and CEO Bonnie H Anderson Sold $765,628 of Shares

Author's Avatar
Jul 22, 2020
Article's Main Image

Chairman and CEO of Veracyte Inc (30-Year Financial, Insider Trades) Bonnie H Anderson (insider trades) sold 23,896 shares of VCYT on 07/22/2020 at an average price of $32.04 a share. The total sale was $765,628.

Veracyte Inc is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The Company's first commercial solution, the Afirma Thyroid FNA Analysis, centers on the proprietary Afirma Gene Expression Classifier. Veracyte Inc has a market cap of $1.57 billion; its shares were traded at around $31.39 with and P/S ratio of 12.42. Veracyte Inc had annual average EBITDA growth of 31.40% over the past five years. GuruFocus has detected 1 severe warning sign with Veracyte Inc. .

CEO Recent Trades:

  • Chairman and CEO Bonnie H Anderson sold 23,896 shares of VCYT stock on 07/22/2020 at the average price of $32.04. The price of the stock has decreased by 2.03% since.

CFO Recent Trades:

  • COO / CFO Keith Kennedy sold 86,424 shares of VCYT stock on 07/06/2020 at the average price of $28.2. The price of the stock has increased by 11.31% since.

Directors and Officers Recent Trades:

  • Chief Commercial Officer John Walter Jr Hanna sold 11,947 shares of VCYT stock on 07/21/2020 at the average price of $32.07. The price of the stock has decreased by 2.12% since.
  • Director Evan/ Fa Jones sold 30,000 shares of VCYT stock on 07/15/2020 at the average price of $28.93. The price of the stock has increased by 8.5% since.
  • Chief Scientific & Med Officer Giulia C Kennedy sold 16,738 shares of VCYT stock on 07/13/2020 at the average price of $29.66. The price of the stock has increased by 5.83% since.
  • Director Robert S Epstein sold 10,000 shares of VCYT stock on 07/13/2020 at the average price of $29.73. The price of the stock has increased by 5.58% since.

For the complete insider trading history of VCYT, click here

.